Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
The importance of a multimodal approach to pain management
The shift from viewing pain as simply a symptom opens up opportunities to greatly improve the way it is treated, writes PainWISE MD Joyce...
The heat of the moment: managing children with pain or fever
Acute pain or fever is common in children. Pain occurs as a result of injury, illness, teething and necessary medical procedures.
A lengthy legacy
Warwick Plunkett AM, FPS, twice a former National President of PSA, is the NSW Lifetime Achievement Award winner for 2023.
Pharmacists could play key role in clinical trial recruitment
Public knowledge of where to access resources for patient clinical trials could be supported by pharmacists, a contributor to pharmacy policy has said.
Mitch Kirkman,...
COVID-19 spreading locally
Health authorities have urged Australians returning from Iran to self-quarantine for 14 days as Australia reports its first cases of human-to-human transmission of COVID-19.
There...
SSRIs for mild cognitive impairment to Alzheimer’s disease
Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment?
An estimated 10% of people...
